Screening compounds and libraries for hit identification in drug development

Our Maybridge screening compounds and libraries have been at the forefront of innovative screening compound design for over 50 years, supporting the needs of drug discovery scientists in their pursuit of novel molecules of pharmaceutical interest.

The drug discovery process is long and expensive. Our aim is to shorten this process by producing high-quality, hit-like, lead-like, and drug-like compounds that generate valuable data from screening programs.

Contact us

Accelerating drug discovery

Availability and stock quantities

Typically, about 95% of the compounds in our collection are available in >5 mg stock quantities and over 90% of the compounds are available in >50 mg stock quantities. A large proportion of our collection is available in gram quantities—this means we can ensure a very high level of re-supply of originally tested compounds. We provide most major brands of plates and vials, but are happy to use those supplied by customers on request.


Supply formats

In order to facilitate screening, selected compounds are available in two pre-plated formats and in vials with stock available for follow-up when required.

  • 96-well plates with 1 μmol dry film
  • 384-well microplates with 0.25 μmol dry film

96-well plates may be provided at mass ≥2 µmol or ≥0.5 mg as powder, dry films, or frozen DMSO solutions. 96- or 384-well plates may be provided at mass 0.1 µmol or 0.01 mg as dry films or frozen DMSO solutions. Compounds may also be ordered in vials at mass 2 µmol or 0.5 mg as powder or DMSO solutions.

Our Maybridge compounds team can provide most major brands of plates and vials, but we are happy to use those supplied by customers on request.
 

Services and support

Maybridge library—Download any or all of the Maybridge library structure files.

Contact us for more information or to place an order

CMD SchemaApp code